Drugmaker Sanofi: Net profit rose 26 percent in 4th quarter on lower charge for drug Lemtrada
February 05, 2015 at 00:36 AM EST
Sanofi SA says its net profit soared 26.3 percent in the fourth quarter thanks to a lower charges against its Lemtrada multiple sclerosis treatment.